Hansoh Pharma, Hongqiao tap Asia CB market

By Jonathan Breen
08 Jan 2021

Hong Kong-listed Hansoh Pharmaceutical Group and China Hongqiao Group have added to the burst of convertible bond activity in the first week of 2021, raising a combined $900m from the equity-linked market on Thursday.

The duo came alongside Taiwan’s Win Semiconductors Corp, which printed a $500m negative yielding CB, the fourth deal in Asia’s equity-linked market this week. The three Thursday trades followed a €230m CB from Zhejiang Expressway on Tuesday

“What I found interesting [on Thursday] night was how ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial